Pfizer seeks FDA approval for its Covid-19 pill Paxlovid

• If granted approval, Pfizer will be allowed to sell the drug Paxlovid commercially

Pfizer Inc (NYSE: PFE) has sought the Food and Drug Administration to grant full approval of its Covid-19 antiviral pill.

If granted approval, Pfizer will be allowed to sell the drug Paxlovid commercially.

Until now, the federal government has authorized the pill for emergency use and also has been directing the pills’ distribution.